NRAS and colorectal carcinoma: Regarding CRC Radiogenomics, Yang et al. [82] retrospectively investigated whether CT-based radiomic signature could predict KRAS, NRAS, and BRAF mutations in CRC by analyzing a primary cohort (61 patients) and a validation cohort (56 patients).